You choose, we deliver
If you are interested in this story, you might be interested in others from The Journal Gazette. Go to and pick the subjects you care most about. We'll deliver your customized daily news report at 3 a.m. Fort Wayne time, right to your email.


  • Potential sale puts jobs in jeopardy
    Almost 200 jobs are in jeopardy as an Illinois-based lawn and garden company negotiates its sale, according to a filing with the Indiana Department of Workforce Development.
  • New rules on banks' risk in mortgage bonds eased
    New U.S. rules aimed at getting banks to take on more of the risk when they package and sell mortgage securities are being relaxed with an eye to spurring broader home lending.
  • CVS tacks tobacco payment to prescription network
    First, CVS Health pulled tobacco from its store shelves. Now, it plans to make some customers think twice about filling prescriptions at other stores that still sell smokes.

Biomet yearly loss widens

Biomet Inc. missed the mark by millions when it released its preliminary earnings estimate on July 11.

The Warsaw-based orthopedic devices-maker today reported final quarterly and annual results that included a net loss of $623 million for the fiscal year ended May 31. That’s 63 percent more than the $382 million loss initially reported and 36 percent more than the $459 million loss reported for the preceding 12 months.

Special items totaled almost $1.23 billion during fiscal 2013, including a $567 million non-cash charge related to Biomet’s dental reconstructive and Europe reporting units. The new total is about $300 million more than estimated in the preliminary report.

Statements attributed to Jeffrey Binder, president and CEO, remained the same as they were seven weeks ago, however. He said opportunities for innovation and differentiation remain in the industry.